Physician profile
Aaron A Berg
NPI 1033485842
$420,972.00
in general payments reported to CMS, 2019-2025
6 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $29K · 2021: $48K · 2022: $12K · 2023: $20K · 2024: $91K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $136K · Consulting Fee: $62K · Travel and Lodging: $42K · Food and Beverage: $6,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $136,405.00 |
| Consulting Fee | $61,602.50 |
| Travel and Lodging | $42,068.08 |
| Food and Beverage | $6,947.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $384,667.48 | 2019-2025 | Exparel, Iovera, Zilretta |
| Atricure, INC. | $32,620.70 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Avanos Medical | $2,869.40 | 2019 | |
| Solventum Corporation | $562.50 | 2025 | 3m Tegaderm |
| Heron Therapeutics, INC. | $140.01 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $111.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.